Clinical Research Solutions for Graft-Versus-Host-Disease Studies Date Published: Mar 29, 2022 Brochure Signant’s comprehensive clinical research solutions and services enable better graft-versus-host disease (GVHD) studies by improving endpoint data quality and increasing operational efficiencies. Our solutions help researchers: Capture more accurate and complete PRO data Deliver the right medications to the right participants at the right time Reduce participation burdens Conduct multinational research more efficiently and effectively Learn more by downloading our brochure. Download Now Share: LinkedInTweet Recommended Resources Paper vs ePRO: Clinical Data Collection Methods Download Now Whitepaper Signant SmartSignals RTSM Download Now Brochure Article Consider Decentralized Clinical Trial (DCT) Design From the Start In this Q&A with Outsourcing Pharma, Signant Health’s Bill Byrom discusses the importance of designing protocols to meet the specific... Download Now